Trials / Completed
CompletedNCT06151210
Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis
A Multicenter, Randomized, Double-blind, Active-controlled, Parallel, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 467 (actual)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate the efficacy and safety of DA-5219 in patients with acute or chronic gastritis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DA-5219 | 1 tablet/day |
| DRUG | Stillen® Tab | 3 tablets/day |
| DRUG | DA-5219 Placebo | 1 tablet/day |
| DRUG | Stillen® Tab Placebo | 3 tablets/day |
Timeline
- Start date
- 2024-01-31
- Primary completion
- 2025-07-10
- Completion
- 2025-07-15
- First posted
- 2023-11-30
- Last updated
- 2025-08-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06151210. Inclusion in this directory is not an endorsement.